{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:09:10Z","timestamp":1783321750209,"version":"3.54.6"},"reference-count":35,"publisher":"Pensoft Publishers","issue":"2","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FM"],"abstract":"<jats:p><jats:bold>Introduction<\/jats:bold>: In the period between 1997 and 2010, sibutramine-containing drugs were widely prescribed for obesity and over-weight management. Due to safety concerns, in 2010 all medicines containing sibutramine were urgently withdrawn from the USA and European pharmaceutical market. Although sibutramine is no longer available in pharmaceutical products, there have been numerous reports of mislabeled weight-loss dietary supplements containing sibutramine.<\/jats:p>\n          <jats:p><jats:bold>Aim<\/jats:bold>: This work aimed to develop and validate an accurate and sensitive high-performance thin-layer chromatographic method for the detection of sibutramine.<\/jats:p>\n          <jats:p><jats:bold>Materials and methods<\/jats:bold>: The method was developed using a CAMAG HPTLC system. Silica gel 60 F254 aluminum HPTLC plates were used as stationary phase and toluene:ethyl acetate:methanol (7:2:1 v\/v\/v) as mobile phase.<\/jats:p>\n          <jats:p><jats:bold>Results<\/jats:bold>: The calibration curve was built in the range of 0.250\u20131.250 \u03bcg\/band. The method provided satisfactory linearity, specificity, precision, and accuracy. The LOD and the LOQ were 0.0765 \u03bcg\/band and 0.2318 \u03bcg\/band, respectively.<\/jats:p>\n          <jats:p><jats:bold>Conclusions<\/jats:bold>: The method allows for the simultaneous analysis of multiple samples as well as the rapid and sensitive monitoring of sibutramine levels in dietary supplements.<\/jats:p>","DOI":"10.3897\/folmed.66.e121218","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T11:43:50Z","timestamp":1714477430000},"page":"255-263","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a high-performance thin-layer chromatography method for detection of sibutramine in dietary supplements"],"prefix":"10.3897","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-4867","authenticated-orcid":true,"given":"Vanya R.","family":"Kozhuharov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzhevdet","family":"Chakarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-7868","authenticated-orcid":true,"given":"Stanislava","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalin","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2258","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"121218_B1","doi-asserted-by":"crossref","unstructured":"1. Gasmi A, Mujawdiya PK, Nehaoua A, et al. Pharmacological treatments and natural biocompounds in weight management. Pharmaceuticals [Internet] 2023; 16(2):212. Available from: https:\/\/www.mdpi.com\/1424-8247\/16\/2\/212","DOI":"10.3390\/ph16020212"},{"key":"121218_B2","unstructured":"2. WHO. World Health Organisation. Obesity [Internet] 2023 [cited 2023 Jun 8]. Available from: https:\/\/www.who.int\/health-topics\/obesity"},{"key":"121218_B3","doi-asserted-by":"crossref","unstructured":"3. James WPT, Caterson ID, Coutinho W, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med [Internet] 2010; 363(10):905\u201317. Available from: http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa1003114","DOI":"10.1056\/NEJMoa1003114"},{"key":"121218_B4","doi-asserted-by":"crossref","unstructured":"4. Scheen AJ. Cardiovascular risk-benefit profile of sibutramine. Am J Cardiovasc Drugs [Internet] 2010; 10(5):321\u201334. Available from: http:\/\/link.springer.com\/10.2165\/11584800-000000000-00000","DOI":"10.2165\/11584800-000000000-00000"},{"key":"121218_B5","doi-asserted-by":"crossref","unstructured":"5. Scheen AJ. Sibutramine on cardiovascular outcome. Diabetes Care [Internet] 2011; 34(Suppl_2):S114\u20139. Available from: http:\/\/care.diabetesjournals.org\/cgi\/doi\/10.2337\/dc11-s205","DOI":"10.2337\/dc11-s205"},{"key":"121218_B6","doi-asserted-by":"crossref","unstructured":"6. Fujioka K, Seaton TB, Rowe E, et al. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes Obes Metab [Internet] 2000; 2(3):175\u201387. Available from: http:\/\/doi.wiley.com\/10.1046\/j.1463-1326.2000.00081.x","DOI":"10.1046\/j.1463-1326.2000.00081.x"},{"key":"121218_B7","doi-asserted-by":"crossref","unstructured":"7. Florentin M, Liberopoulos EN, Elisaf MS. Sibutramine-associated adverse effects: a practical guide for its safe use. Obes Rev [Internet] 2008; 9(4):378\u201387. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1467-789X.2007.00425.x","DOI":"10.1111\/j.1467-789X.2007.00425.x"},{"key":"121218_B8","doi-asserted-by":"crossref","unstructured":"8. Rodriguez-Guerra M, Yadav M, Bhandari M, et al. Sibutramine as a cause of sudden cardiac death. Shirotani M, editor. Case Rep Cardiol [Internet] 2021; 2021:1\u20135. Available from: https:\/\/www.hindawi.com\/journals\/cric\/2021\/8896932\/","DOI":"10.1155\/2021\/8896932"},{"key":"121218_B9","doi-asserted-by":"crossref","unstructured":"9. Yadav L, Sahu S, Agrawal B, et al. Revisiting the most successful United States Food and Drug Administration-approved anti-obesity drug sibutramine sulfate: a comprehensive pharmacotherapeutic review. Int J Med Phar Sci 2022; 12(12):1\u20139. Available from: https:\/\/ijmps.org\/abstract.php?article_id=217","DOI":"10.31782\/IJMPS.2022.121201"},{"key":"121218_B10","doi-asserted-by":"crossref","unstructured":"10. Phattanawasin P, Sotanaphun U, Sukwattanasinit T, et al. Quantitative determination of sibutramine in adulterated herbal slimming formulations by TLC-image analysis method. Forensic Sci Int [Internet] 2012; 219(1-3):96\u2013100. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073811005950","DOI":"10.1016\/j.forsciint.2011.12.004"},{"key":"121218_B11","doi-asserted-by":"crossref","unstructured":"11. Kim HJ, Lee JH, Park HJ, et al. Monitoring of 29 weight loss compounds in foods and dietary supplements by LC-MS\/MS. Food Addit Contam Part A [Internet] 2014; 31(5):777\u201383. Available from: http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/19440049.2014.888497","DOI":"10.1080\/19440049.2014.888497"},{"key":"121218_B12","doi-asserted-by":"crossref","unstructured":"12. Kozhuharov VR, Ivanov K, Karcheva-Bahchevanska D, et al. Development and validation of gas chromatography-mass spectrometry method for quantification of sibutramine in dietary supplements. Processes [Internet] 2023; 11(8):2337. Available from: https:\/\/www.mdpi.com\/2227-9717\/11\/8\/2337","DOI":"10.3390\/pr11082337"},{"key":"121218_B13","doi-asserted-by":"crossref","unstructured":"13. Vovk I, Glavnik V. Analysis of dietary supplements. In: Instrumental Thin-Layer Chromatography [Internet]. Elsevier; 2015 p. 589\u2013635. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780124172234000212","DOI":"10.1016\/B978-0-12-417223-4.00021-2"},{"key":"121218_B14","doi-asserted-by":"crossref","unstructured":"14. Giese SY, Neborsky R. Serotonin syndrome: potential consequences of meridia combined with demerol or fentanyl. Plast Reconstr Surg [Internet] 2001; 107(1):293\u20134. Available from: http:\/\/journals.lww.com\/00006534-200101000-00069","DOI":"10.1097\/00006534-200101000-00069"},{"key":"121218_B15","doi-asserted-by":"crossref","unstructured":"15. Hunsel F, Venhuis BJ, Keizers PHJ, et al. A \u2018natural\u2019 weight loss product containing sibutramine. Drug Test Anal [Internet] 2016; 8(3-4):311\u20134. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dta.1925","DOI":"10.1002\/dta.1925"},{"key":"121218_B16","unstructured":"16. Wr\u00f3bel-Harmas M, Krysi\u0144ska M, Postupolski J, et al. Food supplement-related risks in the light of internet and RASFF data. Przegl Epidemiol 2014; 68(4):613\u20139."},{"key":"121218_B17","doi-asserted-by":"crossref","unstructured":"17. Do TTK, Reich E. HPTLC Screening of weight loss products for deliberately added undeclared synthetic drugs. J AOAC Int [Internet] 2019; 102(3):776\u201380. Available from: https:\/\/academic.oup.com\/jaoac\/article\/102\/3\/776-780\/5658242","DOI":"10.5740\/jaoacint.18-0263"},{"key":"121218_B18","doi-asserted-by":"crossref","unstructured":"18. Patel RB, Patel MR, Batel BG. Experimental aspects and implementation of HPTLC. In: Srivastava M, editor. High-Performance Thin-Layer Chromatography (HPTLC) [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2011, p. 41\u201354. Available from: https:\/\/link.springer.com\/10.1007\/978-3-642-14025-9_3","DOI":"10.1007\/978-3-642-14025-9_3"},{"key":"121218_B19","doi-asserted-by":"crossref","unstructured":"19. Variyar PS, Chatterjee S, Sharma A. Fundamentals and theory of HPTLC-based separation. In: Srivastava M, editor. High-Performance Thin-Layer Chromatography (HPTLC) [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2011, p. 27\u201339. Available from: http:\/\/link.springer.com\/10.1007\/978-3-642-14025-9_2","DOI":"10.1007\/978-3-642-14025-9_2"},{"key":"121218_B20","unstructured":"20. CAMAG. CAMAG\u00ae HPTLC PRO Module APPLICATION | CAMAG [Internet]. 2023 [cited 2023 Aug 4]. Available from: https:\/\/www.camag.com\/product\/camag-hptlc-pro-module-application"},{"key":"121218_B21","unstructured":"21. Raal A, Meos A, Hinrikus T, et al. Dragendorff\u2019s reagent: Historical perspectives and current status of a versatile reagent introduced over 150 years ago at the University of Dorpat, Tartu, Estonia. Pharmazie 2020; 75(7):299\u2013306."},{"key":"121218_B22","doi-asserted-by":"crossref","unstructured":"22. Tietje C, Brouder A, editors. International Conference On Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. In: Handbook of Transnational Economic Governance Regimes [Internet]. Brill | Nijhoff; 2010, p. 1041\u201353. Available from: https:\/\/brill.com\/view\/book\/edcoll\/9789004181564\/Bej.9789004163300.i-1081_085.xml","DOI":"10.1163\/ej.9789004163300.i-1081.897"},{"key":"121218_B23","doi-asserted-by":"crossref","unstructured":"23. Hayun H, Maggadani BP, Amalina N. Determination of sibutramine adulterated in herbal slimming products using TLC densitometric method. Indones J Pharm [Internet] 2016; 27(1):15. Available from: http:\/\/indonesianjpharm.farmasi.ugm.ac.id\/index.php\/3\/article\/view\/1032","DOI":"10.14499\/indonesianjpharm27iss1pp15"},{"key":"121218_B24","doi-asserted-by":"crossref","unstructured":"24. Ariburnu E, Uludag MF, Yalcinkaya H, et al. Comparative determination of sibutramine as an adulterant in natural slimming products by HPLC and HPTLC densitometry. J Pharm Biomed Anal 2012; 64:77\u201381. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708512000660","DOI":"10.1016\/j.jpba.2012.02.004"},{"key":"121218_B25","doi-asserted-by":"crossref","unstructured":"25. Mathon C, Ankli A, Reich E, et al. Screening and determination of sibutramine in adulterated herbal slimming supplements by HPTLC-UV densitometry. Food Addit Contam Part A [Internet] 2014; 31(1):15\u201320. Available from: http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/19440049.2013.861934","DOI":"10.1080\/19440049.2013.861934"},{"key":"121218_B26","doi-asserted-by":"crossref","unstructured":"26. Firozian F, Nili-Ahmadabadi A, Moradkhani S, et al. Adulteration of the herbal weight loss products by the illegal addition of synthetic antiobesity medications: a pilot study. Velotti N, editor. J Obes [Internet] 2021; 2021:1\u20133. Available from: https:\/\/www.hindawi.com\/journals\/jobe\/2021\/9968730\/","DOI":"10.1155\/2021\/9968730"},{"key":"121218_B27","doi-asserted-by":"crossref","unstructured":"27. Kamil M. Identification and detection of undeclared herbal slimming adulterants. Int J PLANT Environ [Internet] 2016; 2(1 and 2):73\u20138. Available from: https:\/\/ijplantenviro.com\/index.php\/IJPE\/article\/view\/1163","DOI":"10.18811\/ijpen.v2i1-2.6620"},{"key":"121218_B28","doi-asserted-by":"crossref","unstructured":"28. Hachem R, Assemat G, Martins N, Balayssac S, et al. Proton NMR for detection, identification and quantification of adulterants in 160 herbal food supplements marketed for weight loss. J Pharm Biomed Anal [Internet] 2016; 124:34\u201347. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851630084X","DOI":"10.1016\/j.jpba.2016.02.022"},{"key":"121218_B29","unstructured":"29. Krivohlavek A, \u017duntar I, Ive\u0161i\u0107 M, et al. Sibutramine in slimming food supplements on the Croatian market determined by validated high-pressure liquid chromatographyelectrospray tandem mass spectrometry method. J Food Nutr Res 2016; 55(3):222\u20138."},{"key":"121218_B30","doi-asserted-by":"crossref","unstructured":"30. Zeng Y, Xu Y, Kee C, et al. Analysis of 40 weight loss compounds adulterated in health supplements by liquid chromatography quadrupole linear ion trap mass spectrometry. Drug Test Anal [Internet] 2016; 8(3-4):351\u20136. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dta.1846","DOI":"10.1002\/dta.1846"},{"key":"121218_B31","doi-asserted-by":"crossref","unstructured":"31. Sissung TM, Cordes LM, Figg WD. The dietary supplement health and education act: are we healthier and better informed after 27 years? Lancet Oncol [Internet] 2021; 22(7):915\u20136. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147020452100084X","DOI":"10.1016\/S1470-2045(21)00084-X"},{"key":"121218_B32","doi-asserted-by":"crossref","unstructured":"32. Dodge T. Consumers\u2019 perceptions of the dietary supplement health and education act: implications and recommendations. Drug Test Anal [Internet] 2016; 8(3-4):407\u20139. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dta.1857","DOI":"10.1002\/dta.1857"},{"key":"121218_B33","doi-asserted-by":"crossref","unstructured":"33. Nisoli E, Carruba MO. A benefit-risk assessment of sibutramine in the management of obesity. Drug Saf [Internet] 2003; 26(14):1027\u201348. Available from: http:\/\/link.springer.com\/10.2165\/00002018-200326140-00004","DOI":"10.2165\/00002018-200326140-00004"},{"key":"121218_B34","doi-asserted-by":"crossref","unstructured":"34. Maughan RJ, Burke LM, Dvorak J, et al. IOC consensus statement: dietary supplements and the high-performance athlete. Br J Sports Med [Internet] 2018; 52(7):439\u201355. Available from: https:\/\/bjsm.bmj.com\/lookup\/doi\/10.1136\/bjsports-2018-099027","DOI":"10.1136\/bjsports-2018-099027"},{"key":"121218_B35","unstructured":"35. WADA. World Anti-Doping Agency [Internet]. 2021 [cited 2021 Oct 25]. Available from: https:\/\/www.wada-ama.org\/en"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"https:\/\/foliamedica.bg\/article\/121218\/download\/pdf\/","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article\/121218\/download\/xml\/","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article_preview.php?id=121218&skip_redirect=1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T11:44:03Z","timestamp":1714477443000},"score":1,"resource":{"primary":{"URL":"https:\/\/foliamedica.bg\/article\/121218\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,30]]}},"URL":"https:\/\/doi.org\/10.3897\/folmed.66.e121218","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"value":"1314-2143","type":"electronic"},{"value":"0204-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}